US 9023795
Angiogenesis-inhibiting peptide and application thereof
granted A61KA61K38/00A61K38/179
Quick answer
US patent 9023795 (Angiogenesis-inhibiting peptide and application thereof) held by SHANGHAI FIRST PEOPLE'S HOSPITAL expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SHANGHAI FIRST PEOPLE'S HOSPITAL
- Grant date
- Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/00, A61K38/179, A61K38/18, A61K38/1891